Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001466049-11-000011)

Filing Details

Accession Number:: 0001466049-11-000011
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-02-10 17:28:29
Reporting Period:: 2011-02-08

Filing Date:: 2011-02-10
Accepted Time:: 2011-02-10 17:28:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1322505	Biodel Inc	BIOD	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1452204	S Paul Bavier	C/O Biodel Inc. 100 Saw Mill Road Danbury CT 068810	General Counsel/Corp. Sec.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-02-08	10,450	$0.00	33,446	No	4	M	Direct
Common Stock	Disposition	2011-02-09	3,658	$2.04	29,788	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Acquisiton	2009-12-15	10,450	$0.00	10,450	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2011-02-08	2011-02-08	No	4	M	Direct

Footnotes

Each Restricted Stock Unit was the economic equivalent of one share of common stock. The shares of common stock were distributed upon settlement of vested Restricted Stock Units originally granted on December 15, 2009.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/21/2010.